CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
Yoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, Soyoung Won, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Dae-Hyun Yoo, Sang-Cheol Bae
Korean J Intern Med. 2018;33(5):1016-1024.   Published online 2017 March 13    DOI: https://doi.org/10.3904/kjim.2016.214

Excel Download

Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
The Korean Journal of Internal Medicine. 2018;33(5):1016-1024   Crossref logo
Link1 Link2 Link3

Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis
Arthritis Care & Research. 2013;65(11):1722-1731   Crossref logo
Link1

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
Intestinal Research. 2014;12(1):12   Crossref logo
Link1

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
Arthritis & Rheumatism. 2008;58(5):1258-1263   Crossref logo
Link1 Link2

Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis
Advances in Therapy. 2016;33(5):807-823   Crossref logo
Link1 Link2 Link3

Incidence of Tuberculosis in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents following Latent Tuberculosis Infection Screening Strategies
Journal of Rheumatic Diseases. 2015;22(4):223   Crossref logo
Link1 Link2 Link3

Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection
Internal Medicine Journal. 2016;46(3):281-287   Crossref logo
Link1

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
Arthritis & Rheumatology. 2016;68(6):1337-1345   Crossref logo
Link1

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Arthritis & Rheumatism. 2008;58(S2):S92-S101   Crossref logo
Link1 Link2

PMS6 Treatment Pattern Visualization of Medicare Patients Diagnosed with Rheumatoid Arthritis and Initiating Tumor Necrosis Factor Therapy
Value in Health. 2012;15(4):A34   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.